Publication: 2151

Publication: 2151

Impact of intrinsic subtype by PAM50 and other gene signatures on pathologic complete response (pCR) rates in triple-negative breast cancer (TNBC) after neoadjuvant chemotherapy (NACT) +/- carboplatin (Cb) or bevacizumab (Bev): CALGB 40603/150709 (Alliance)

URL

Google Scholar

Citation:: Cancer Res vol 75 (suppl 9) S4-5

Meeting Instance:: SABCS 2014
Year:: 2015
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: Secondary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: 3313 3660

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:
Grants:

Corr. Author:
Authors:: William M. Sikov William T. Barry Katherine A. Hoadley Brandelyn N. Pitcher Baljit Singh Sara M Tolaney Charles S Kuzma Timothy J Pluard George Somlo Elisa R Port Mehra Golshan Donald A Berry Olwen M Hahn Lisa A Carey Charles M. Perou Clifford A Hudis Eric P Winer

Networks:: CA043, LAPS-CT018, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NC007, LAPS-NY016, NY021, RI005, SCOR

Study: CALGB-40603
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: